Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Time-Sensitive Nebulization Mode Converter

NCT: NCT07633223 · COMPLETED

NCT IDNCT07633223
StatusCOMPLETED
Start Date2024-09-01
Completion2025-08-30
SponsorBeni-Suef University (OTHER)
First posted
Last updated

Brief Summary

This study utilizes a randomized crossover design to evaluate and compare the clinical and technical efficacy of different nebulization modes for aerosol drug delivery. By implementing a within-subject comparison, each participant will receive the two designated aerosol delivery interventions under distinct, controlled protocols. The primary objective is to determine whether synchronization of aerosol generation with the inspiratory phase could improve respirable aerosol delivery, enhance pulmonary drug deposition, and reduce aerosol loss during exhalation without significantly altering aerosol aerodynamic particle size distribution characteristics. This research aims to optimize nebulization practices and establish evidence-based guidelines for enhanced respiratory drug administration.

Frequently Asked Questions

What is Evaluation of Time-Sensitive Nebulization Mode Converter?

Evaluation of Time-Sensitive Nebulization Mode Converter is a clinical trial registered under NCT07633223. Current status: COMPLETED.

What is the status of NCT07633223?

The current status of NCT07633223 (Evaluation of Time-Sensitive Nebulization Mode Converter) is: COMPLETED.

When did Evaluation of Time-Sensitive Nebulization Mode Converter start?

Evaluation of Time-Sensitive Nebulization Mode Converter started on 2024-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.